Quest Diagnostics Inc
(NYSE:DGX)
$
153.02
-0.4 (-0.26%)
Market Cap: 17.08 Bil
Enterprise Value: 23.40 Bil
PE Ratio: 20.57
PB Ratio: 2.52
GF Score: 86/100 Quest Diagnostics Inc at UBS Global Healthcare Conference Transcript
May 24, 2022 / 07:30PM GMT
Release Date Price:
$140.09
(+0.39%)
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution
Good afternoon, everybody. Thanks for being here on Day 2, the end of Day 2 of the UBS Healthcare Conference. I'm Kevin Caliendo, UBS health care services analyst, and I am happy to be joined by the management team from Quest Diagnostics, Steve Rusckowski, Chairman, CEO and President; and Jim Davis, CEO-elect; and the EVP of General Diagnostics business. Gentlemen, thank you so much for coming today.
Thanks for coming to New York. Hope the flights and everything was good.
Stephen H. Rusckowski
Quest Diagnostics Incorporated - Chairman, President & CEO
It's easy because I live here.
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution
Is this your first sort of in-person.
Stephen H. Rusckowski;Kevin
Quest Diagnostics Incorporated - Chairman, President & CEO
No.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot